You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Health & wellness

Cancer science leans more on industry funds

Trend fills gap left by budget cuts, but also worries many researchers

WASHINGTON — Cancer institutes across the country are relying more heavily than ever on pharmaceutical industry funding for research as the proportion of federal support shrinks, raising concerns among scientists struggling to compete for the next oncology breakthrough.

At Boston’s Dana-Farber Cancer Institute, industry money makes up nearly a quarter of its research support, compared with 10 percent a decade ago, according to the institute. The federal share of research money has eroded during that time from more than 70 percent of funding to just under 60 percent.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week